



Pain is an unpleasant sensory or emotional experience 
associated with actual or potential tissue damage or described 
in terms of such damage. Phantom limb pains (PLPs) are 
painful sensations referred to absent limbs. With the foregoing 
in mind, PLP must be differentiated from entities such as 
“phantom limb sensation (PLS)” and “stump pain/residual 
limb pain (RLP).” PLP phenomenon was first described in 
1552 by the French surgeon, Ambroise Pare, but the title 
was given to this entity in 1872 by the American neurologist, 
Silas Weir Mitchell. PLP is a real pain and can range from 
brief flashes of mild pain to constant severe pain. It is a 
common complication of limb amputations with a reported 
prevalence of 72% in a study.[1] Whereas most PLPs arise 
from amputated limbs, congenital limb absence accounts for 
a lesser prevalence.[2]
Limb amputations in Nigeria
Limb amputations are common orthopedic surgical procedures 
in Nigeria and provide a major means of saving lives when 
limb salvage is not feasible, especially with patients presenting 
late to health-care facilities with advanced limb pathologies. 
A national review of extremity amputations in Nigeria 
using data collected over two decades ago had reported 
the following indications for amputation; trauma (34%), 
complication following traditional bone setting (23%), 
malignant tumors (14.5%), diabetic gangrene (12.3%), 
infections (5.1%), peripheral artery disease (2.1%), and 
burns (2.1%).[3] Recent data, however, indicate a changing 
trend with a greater preponderance of diabetic foot gangrene 
as the most common indication for limb amputations[4-6] or 
following closely after trauma and gangrene from traditional 
bonesetters mismanaged fractures.[7,8] This is not unexpected 
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given the predicted global increase in the prevalence of diabetes 
from 2011 to 2030 estimated at 50.7%, with an average annual 
growth of 2.7%, which is 1.7 times the annual growth of the 
total world adult population.[9]
Phantom limb pain in Nigeria
In contrast to the known high prevalence of PLP among 
amputees worldwide, it is an understatement to say that 
this common distressing complication of amputation is 
underrecognized, unreported, or simply ignored by health-care 
workers here in Nigeria. Studies of PLP in Nigeria and indeed 
Africa are sparse or nonexistent. A literature search did not 
find any previous study of PLP in Nigeria, but we found 
three studies on complications of limb amputation remotely 
mentioning PLP with a very low prevalence of 5.5%, 3.3%, 
and 14.6%, respectively.[5,7,10]
The phantom limb pain challenge
PLP is a chronic neuropathic pain that adversely affects 
patients’ quality of life, and amputees with phantom pain have 
been found to have a poorer health-related quality of life than 
amputees without phantom pain.[11] The morbidity associated 
with PLP is considerable, with some patients having severe 
pain intensity, limitation of social activities, depression, loss 
of sleep, and attempted suicides.[12] The plight of the amputees 
with PLP is worsened because the mechanisms underlying 
PLP are so poorly understood that 33% of the PLP patients 
report that their health-care providers told them there was 
no treatment available.[13] Several treatment options ranging 
from pharmacological to physical and surgical interventions 
have been offered to the patients suffering from PLP, yet a 
good proportion reports no relief or clinical improvement in 
spite of all these offerings.[14] With the increasing incidence 
of limb loss in Nigeria and elsewhere,[15,16] there is growing 
interest in preventing or treating PLP. This highlight on the 
underrecognition and undertreatment of PLP among Nigerian 
amputees is intended to provide the impetus for improved 
awareness and care by health-care providers in Africa.
Methodology
Ethical consideration
Ethical approval for the study with protocol number: 201 was 
obtained from the Institutional Review Board of National 
Orthopaedic Hospital, Enugu. The respondents were required 
to sign to a written informed consent form, and for children, this 
was obtained from their parents or guardians. Participation in 
the study was voluntary, with respondents being absolutely free 
to withdraw at any stage as they may wish. The respondents 
were assured that information obtained from them would be 
treated anonymously and confidentially.
Setting
This is a prospective cohort study conducted in National 
Orthopedic Hospital, Enugu, a tertiary regional trauma 
center in Nigeria involving sequential limb amputees 
recruited over a period of 1 year which commenced on 
April 1, 2015.
PatIents and Methods
Informed consent was sought from all patients who underwent 
limb amputation; major or minor and all consenting amputees 
were consecutively enrolled in the study. For children and 
minors, the informed consent was obtained from their parents 
or guardians.
Exclusion criteria
Amputees were excluded if their hospital stay after admission 
was for a period of <7 days; on account of discharge, death 
or transfer to another facility. All amputees who did not give 
consent to participate in the study or who had a history of 
dementia were also excluded.
Data collection
Information sought in the pro forma for data collection 
included the demographic data of the patient (such as gender, 
age, occupation, educational level, and contact telephone), 
American Society of Anesthesiologists (ASA) physical status 
grade, any existing comorbidity, technique of anesthesia 
used for the amputation, cause of the pathology indicating 
the amputation, site of extremity of the surgery, level of 
amputation, any documented recognition of PLP in the patient’s 
medical record by the managing health-care providers, and 
any treatment offered for the PLP. Patients were assessed 
postoperatively in hospital at 1 week, at 6 months, and 
12 months by telephone for the presence of PLP, including 
the description of the pain from a list of words provided and 
its intensity. Detailed explanation was given to the amputees 
in order to distinguish PLP from other components of the 
phantom limb phenomena such as residual limb/stump pain and 
nonpainful phantom sensation. The 11-point Numeric Rating 
Scale (NRS) was used to assess pain intensity as 0 for no pain 
and 10 for worst imaginable pain. For level of amputation, 
major amputation was defined as amputations proximal to or 
through the ankle in the lower limb or the wrist in the upper 
limb, whereas minor amputation was defined as preservation 
of at least part of the foot or hand.
After discharge from the hospital, all the participants were 
evaluated by telephone survey at 6 months and 12 months for 
the presence of PLP, including a description of the pain and its 
intensity, in continuation of the direct face-to-face assessment 
done while on admission at 1 week postamputation.
At 2 years from the commencement of the study, when the 
last recruited participant had been surveyed for the presence 
of PLP, the medical records of all the participants with PLP 
were reviewed, and any documentation, comment, or treatment 
regarding PLP by any health-care worker (surgeons and 
physiotherapists) was noted.
Statistical analysis
Data entry and statistical analysis was performed using IBM 
Statistical Package for the Social Sciences SPSS (version 22, 
SPSS Inc., Chicago, Illinois, USA) for Windows. Frequency 
distributions and cross-tabulations were generated. The 
Chi‑square test of statistical significance and multivariate 
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analysis using binary logistic regression were used in the 
analysis, and the level of statistical significance was determined 
by P < 0.05.
In determining the factors affecting PLP, the age of the 
respondents was categorized into three groupings including 
those <40 years, 40–64 years, and those 65 years and above.
Variables that had P < 0.2 on bivariate analysis (including age 
of respondents in groups, presence of comorbidities, ASA 
grade of respondent, and diagnosis before amputation) were 
entered into the logistic regression model to determine the 
predictor of PLP. The result of the logistic regression analysis 
is reported using adjusted odds ratio and 95% confidential 
interval, and the level of statistical significance was determined 
by P < 0.05.
results
One hundred and fourteen limb amputations were carried 
out in 113 patients over the period of 1 year, with one patient 
being admitted twice during the course of the study for the 
amputation of the second lower limb on the same account 
due to diabetic foot gangrene. Six of the amputees died during 
the 1-year period of follow-up, and as such, their PLP status 
could not be fully ascertained. Of these, three died within 
3 days postoperative of septicemia associated with diabetic 
foot gangrene and neglected traumatic wounds, whereas the 
other three died later within 6 months of the surgery from 
unknown causes outside the period of hospital admission. All 
the patients approached for informed consent agreed to take 
part in the cohort study, and the only dropouts were those 
indicated above. The amputees including those who had minor 
limb amputations stayed on admission in our health facility for 
a minimum duration of 1 week in consideration of the safety 
of the prevailing environment in their respective homes, the 
risk of nosocomial infections in the hospital notwithstanding.
Table 1 shows the sociodemographic and clinical characteristics 
of the amputees. The mean age of the respondents was 
49.5 (20.5) years, with a minimum age of 9 years and 
maximum of 103 years. Majority of the amputations were 
in males, 76/114 (66.7%), whereas most of the amputations 
were carried out in the lower limb, 106/114 (93%). Major 
amputations were predominant, 107/114 (93.7%). Diabetic 
foot gangrene was the leading indication for amputation, 
43/114 (37.7%), and this was closely followed by trauma, 
38/114 (33.3%). Among the six patients who had amputation 
on account of miscellaneous causes, five resulted from chronic 
osteomyelitis, whereas one had lymphedema praecox. Based 
on the level of the amputations, only 6.1% (7/114) were minor. 
The majority of the amputees were ASA Grade III at the time 
of amputation, 52/114 (45.6%), and regional anesthesia was 
the predominant anesthetic technique used, 100/114 (87.7%). 
The three patients that died before the first observation at 
1 week had no opportunity of reporting PLP; as such, only 
the 110 who were interviewed at 1 week were considered in 
determining the prevalence of PLP in the cohort.
The period prevalence of PLP during the 1-year follow-up 
postamputation was 63.6% (70/110). The patient who had 
amputation of both lower limbs reported PLP in one limb but 
not in the other. Only 8.6% (6/70) of the participants reporting 
PLP had a documentation of PLP status in their case file 


















Upper limb 8 (7.0)







Educational attainment of respondents
No formal education 8 (7.0)
Primary education 37 (32.5)
Secondary education 44 (38.6)
Postsecondary education 25 (21.9)
Occupation






ASA physical status grade
Grade I 20 (17.5)
Grade II 36 (31.6)
Grade III 52 (45.6)
Grade IV 6 (5.3)
Diagnosis before amputation
Diabetic foot gangrene 43 (37.7)
Trauma 38 (33.3)
Miscellaneous (Infection, etc.) 6 (5.3)
Malignancy 12 (10.5)
Vascular gangrene 15 (13.2)
ASA – American Society of Anesthesiologists physical status grade, SD – 
Standard deviation
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by caregivers, and of these, three were treated with simple 
analgesics and/or adjuvants, two received counseling and 
reassurance, whereas one was just ignored [Table 2].
Tables 3 and 4 indicate that the predominant character of 
PLP among the amputees was described as the “biting” and 
“aching” types. Majority of the PLP sufferers experienced pain 
of mild (NRS: 1–3) or moderate intensity (NRS: 4–6), with only 
two patients reporting severe pain: one 7/10 and the other 8/10 
on the NRS, and these were within the 1st week postamputation. 
Of the 70 amputees who reported PLP (not shown in the tables) 
39 (55.7%) reported their highest pain score was in the mild 
pain range, 29 (41.4%) reported their highest pain score to be 
in the moderate range, and two (2.9%) reported the highest pain 
score to be severe. Of the 70 amputees who experienced PLP, 
most had early onset of PLP, with 97% (68/70) developing it 
within 1 week following amputation. At 6-month follow-up, 
30 amputees were experiencing PLP, whereas at 12-month 
follow-up, only 9 amputees were experiencing PLP. The 
character of the pain and its intensity also varied over time, with 
most patients having decreasing pain intensity. Three of the 
amputees in this study (4.3%), however, reported progressively 
worsening PLP even at 1 year after amputation.
None of the sociodemographic and clinical factors were found 
to be associated with the development of PLP. The ASA grade 
of the amputees at amputation which yielded a P value of 
0.019 on bivariate analysis when subjected to binary logistic 
regression analysis was not significant, implying that it was a 
confounding factor [Table 5].
dIscussIon
The results of the present study indicate that PLP is a very 
common complication of limb amputations but poorly 
recognized and undertreated. The sheer magnitude of limb 
amputations in this single-center study over a period of 1 year 
provides a stimulus to investigate this population of patients for 
a common complication associated with amputations, namely 
PLP. With a limb amputation rate of 114/year in this center, the 
figure is far greater than that of some other tertiary health‑care 
institutions reported in Nigeria: 94/10 years,[4] 90/2 years,[5] 
165/7 years,[6] and 192/11 years,[7] respectively.
Prevalence of phantom limb pain
The period prevalence of PLP (63.6%) obtained in the present 
study during the 1-year follow-up is in contrast to the very 
low prevalence of 5.5%,[5] 3.3%,[7] and 14.6%[10] quoted in 
three Nigerian sources which remotely mentioned PLP while 
considering complications of limb amputation. The data on 
PLP in these three quoted studies with very low prevalence 
of PLP were extracted retrospectively from caregiver 
documentation in the patient’s case files. This method of 
data collection with regard to PLP has been known to grossly 
underestimate its prevalence since most of the patients do not 
spontaneously volunteer information about experiencing PLP 
for fear of being stigmatized as having spiritual or psychiatric 
problems to the extent of complaining of pain in absent limb. 
This underrecognition of PLP prevalence by data acquired from 
this source was also underscored by a retrospective survey 
which revealed that only 40% of those who admitted having 
PLP had it documented in their medical record by health-care 
providers (doctors, nurses, and physical therapists) despite the 
long months/years since amputation.[17] If the data in the present 
study had been sourced from the amputees’ case files, only 6 out 
of 110 participants would have been identified as developing 
PLP, resulting in a prevalence of 5.5% being quoted, clearly 
an underestimate of the prevalence obtained upon explicitly 
asking patients about their PLP experience.





PLP documented in case file
Yes 6 (8.6)
No 64 (91.4)
Any treatment given for PLP n=6
Yes 5 (83.3)
No 1 (16.7)
Type of treatment given
Counseling/reassurance 2 (40.0)
Carbamazepine tablets 1 (20.0)
Chlorzoxazone/diclofenac/paracetamol tablets 1 (20.0)
Pregabalin/diclofenac tablets 1 (20.0)
PLP – Phantom limb pain
Table 3: Descriptors of the phantom limb pain among the 
amputees over time (n=70)
Variable Frequency (%)
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Jensen et al. had found a PLP incidence of 72%, 65%, and 
59%, respectively, at 8 days, 6 months, and 2 years after limb 
amputation in a prospective study involving 58 patients.[18] 
Another prospective study, multicenter, by Bosmans et al. 
on 85 limb amputees reported PLP prevalence rates of 32%, 
27%, 23%, and 27% from the 73 lower-limb amputees and 
50%, 78%, 57%, and 67% from the 12 upper limb amputees at 
6 months, 1½ years, 2½ years, and 3½years, respectively.[19] In 
the latter study, however, only PLP sufferers who experienced it 
a few times a day or more frequently were recognized, whereas 
those who experienced it a few times a week or less frequently 
were excluded. This introduction of cutoff point for recognition 
of existing PLP probably explains the low prevalence in their 
study. Furthermore, 6 months after amputation when the first 
observation of PLP was due, 37% of the initially recruited 
134 amputees had been lost to follow-up because they died 
or dropped out. Thus, out of the initial amputee population of 
225, 134 were eventually recruited, and of these, 37% were lost 
to follow‑up because they died or dropped out within the first 
6 months when the first observation for PLP was due, leaving 
only 85 (37.8% of the amputee population) for consideration 
and analysis. This number further declined to 18 by the time of 
the fourth observation at 31/2 years postamputation for sundry 
reasons. How these losses would impact the representative 
nature of their amputee population is a matter of conjecture. 
Further insight into the impact of methodology on the 
prevalence rate quoted for PLP in different studies is provided 
by the Wartan et al. study which was a retrospective survey 
in a very elderly population of all male, traumatic amputees, 
in which 87% of the respondents had a lost limb 30–50 years 
earlier.[13] Out of 590 amputees initially recruited for the study, 
only 508 eventually provided categorical responses on PLP 
presence or otherwise, and of these, 326 affirmed experiencing 
PLP. The authors quoted a prevalence of 55.2% (326/590) in 
what ought to be 64.2% (326/508).
Another potential source of the wide difference in PLP 
prevalence quoted in some studies is the difficulty which 
the respondents may have in discriminating between PLP, 
PLS, and RLP.[20] In the study by Wartan et al., 18 out of 526 
respondents categorically declared this confusion[13] and a 
much higher number may be silent about their confusion or 
may not know that they are making false declaration. It was 
in recognition of this potential pitfall that this study ensured 
that the first assessment was done as a face‑to‑face interview, 
with detailed explanation to enable the amputees discriminate 
PLP, from PLS and RLP. Although undocumented as part of 
the data in this study, in the course of this direct interview, 
most of the PLP sufferers expressed surprise and some relief 
that someone knows and cares about their otherwise silent 
and embarrassing agony which they were scared to report for 
fear of social recrimination in respect of “complaint of pain 
in nonexistent limb.”
The only study to date conducted in Africa on PLP was about 
two decades ago in the year 2000 by Lacoux et al. which 
reported a low prevalence of PLP: 32.5% (13/40) of the 
amputees and 29% (15/51) of the amputations.[21] Their work 
was a cross-sectional survey of traumatic upper limb amputees 
conducted in Amputee Camp in Sierra Leone. The fact that their 
study was limited to traumatic upper limb amputees (also with 
exclusion of amputations distal to the wrist) and meant as an 
initial assessment of 40 out of 153 upper limb amputees in the 
camp without any random sampling being applied may all have 
affected the representative nature of their cohort with respect to 
PLP. The authors further disclosed communication challenges 
with the amputees who predominantly spoke the local Krio 
language and that translations into Krio were not exact or not 
available, despite using interpreters. There was also a tense and 
deteriorating security situation during the pain assessment which 
forced the researchers to hurriedly and prematurely conclude the 
study and evacuate; both constraints which they acknowledged 
could account for the low prevalence of PLP in their study. It was 
also revealed that during the surgical amputation procedures, all 
the patients in the Lacoux et al. study[21] had been anesthetized 
with ketamine, a N-methyl-D-aspartate receptor antagonist 
with reports of efficacy in the treatment of some neuropathic 
pains,[22,23] but any contribution by this to the low prevalence of 
PLP in their study cannot be presumed. However, these logistical 
and methodological issues may have contributed to the low 
prevalence of PLP in their study.
Prevalence studies on PLP also contend with the fact that many 
amputees have had multiple amputations, and as such, while 
Table 4: Intensity of phantom limb pain among the 
amputees over time (n=70)
Variable Frequency (%)
























NRS – Numeric Rating Scale pain score
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some authors have used the total number of amputees as the 
reference population sample, others opted for the total number 
of amputations in their computation of PLP prevalence, as 
shown in the study by Lacoux et al. reporting a prevalence of 
PLP: 32.5% (13/40) of the amputees and 29% (15/51) of the 
amputations;[21] thus, interpretation of the prevalence quoted 
in PLP studies should be made with circumspection. This does 
not appear to have been an issue in the present study as only 
one participant had two amputations; the rest had one.
Phantom limb pain characteristics
The onset of PLP among the amputees that developed it in 
this study was quite early, with 97% developing it by the end 
of the 1st week, and this compares well with the 75% reported 
within the few days postamputation by Krane and Heller.[17]
Assessment of pain intensity is considered one of the core 
outcome domains in clinical pain research, and the NRS is 
recommended.[24] The NRS used to rate pain intensity in this 
study is among the proven, valid, and reliable subjective 
methods of pain intensity measurement. It is unidimensional 
and easy to use, with most patients demonstrating high 
compliance, sensitivity, responsiveness, and applicability 
compared to the Visual Analog Scale and Verbal Rating 
Scale.[25,26]
The participants with PLP in this study reported their greatest 
pain intensity as either mild (1–3 in the 11-point NRS) or 
moderate (4–6 in the 11-point NRS) during the course of our three 
observations, except two patient who had severe pain (7/10 and 
8/10 in the 11-point NRS) within the 1st week postamputation 
period, with 55.7% having mild pain, 41.4% having moderate 
pain, and only 2.9% having severe pain. These NRS scores 
appear to be lower than the mean intensity of 5.1 ± 2.2 and 
5.6 reported by Yin et al. and Wartan et al., respectively,[12,13] 
although pain intensity in each of their respondents was 
sampled only once. In the study by Yin et al., 31.9% of the PLP 
sufferers had pain of severe intensity.[12] Similarly, in another 
retrospective cross‑sectional survey utilizing a stratified sample 
of 914 American amputees, a mean pain intensity of 5.5 ± 2.6 
was reported by the PLP sufferers, with majority (38.9%) 
Table 5: Prevalence of phantom limb pain and associated factors in the amputees
Variable Phantom limb pain (n=111) P‡ AOR (95%CI)§
Yes, n (%) No, n (%)
Age of the amputees in groups (years)
<40 27 (75.0) 9 (25.0) 0.193 0.8 (0.2-4.5)
40-64 25 (58.1) 18 (41.9) 0.5 (0.1-1.8)
≥65 18 (56.2) 14 (43.8) 1
Gender
Male 45 (61.6) 28 (38.4) 0.668 NA
Female 25 (65.8) 13 (34.2)
Anesthesia technique
General 9 (64.3) 5 (35.7) 0.919 NA
Regional 61 (62.9) 36 (37.1)
Site of amputation
Upper limb 5 (62.5) 3 (37.5) 0.973 NA
Lower limb 65 (63.1) 38 (36.9)
Degree of amputation
Major 65 (62.5) 39 (37.5) 0.636 NA
Minor 5 (71.4) 2 (28.6)
Presence of comorbidities
Yes 39 (56.5) 30 (43.5) 0.067 1.6 (0.2-15.3)
No 31 (73.8) 11 (26.2) 1
ASA grade of the amputees
Grade I 11 (55.0) 9 (45.0) 0.019 1.0 (0.04-24.7)
Grade II 30 (83.3) 6 (16.7) 7.3 (0.4-131.0)
Grade III 28 (53.8) 24 (46.2) 1.7 (0.1-22.1)
Grade IV 1 (33.3) 2 (66.7) 1
Diagnosis before amputation
Diabetic foot gangrene 20 (48.8) 21 (51.2) 0.139 0.7 (0.2-2.6)
Trauma 28 (75.7) 9 (24.3) 2.8 (0.2-33.3)
Miscellaneous (Infection, etc.) 4 (66.7) 2 (33.3) 4.6 (0.3-81.2)
Malignancy 9 (75.0) 3 (25.0) 1.9 (0.2-17.1)
Vascular gangrene 9 (60.0) 6 (40.0) 1
‡P value on bivariate analysis, §AOR (95% CI) on multivariate analysis. ASA – American Society of Anesthesiologists physical status grade, NA – Not 
applicable, AOR – Adjusted odds ratio, CI – Confidence interval
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reporting severe pain (7–10 in the NRS).[27] The study in an 
African population sample by Lacoux et al. also revealed a PLP 
pain intensity within the range of 2–6 (using the 11-point NRS) 
among the PLP sufferers, which is in the mild‑moderate pain 
spectrum as in this study.[21] All the patients in the present 
study are Africans, and although the influence of race on pain 
intensity reporting has not been widely investigated, Mossey 
found that African Americans are more likely than non-Hispanic 
whites to underreport pain unpleasantness in the clinical setting, 
especially in the presence of physicians who were perceived 
as having “higher social status.”[28] The lower pain intensity 
reported in these two studies on African population samples 
in respect of PLP is, however, contrary to reports by Martinez 
et al.[29] and Creamer et al.,[30] indicating that compared with 
Caucasians, African American individuals report higher levels 
of pain for a number of similar chronic pain conditions including 
cancer and arthritis, respectively.
The most common descriptor of PLP in the study by Lacoux 
et al. was “stabbing,” followed by “pins and needles” with 
“burning” character reported infrequently.[21] The study by 
Wartan et al. similarly reported “stabbing” and “pins and 
needles” as the predominant descriptors with few “burning” 
type pain, whereas in our study, “biting” descriptor was most 
common, followed by “aching,” with “burning” being reported 
infrequently.[13] It would seem that the “biting” descriptor may 
be likened to “stabbing” used in different studies; much as 
the “pricking” may be likened to “pins and needles.” It could 
be observed that Lacoux et al.[21] and Wartan et al.[13] studied 
populations in which trauma was the indication for amputation 
in contrast to the present study which considered all limb 
amputations indicated by diverse pathology but whether this 
factor has any influence on the type of descriptor experienced 
by the amputees has not been evaluated.
We also observed that the course of the PLP changed 
remarkably over time with decreasing prevalence among 
the initial PLP sufferers and most patients having decreasing 
pain intensity. Three of the amputees in this study (4.3%), 
however, reported progressively worsening pain intensity 
even at 1 year postamputation. In the survey by Wartan et al., 
PLP disappeared completely in 16% of the respondents 
reporting PLP, whereas intensity decreased substantially in 
37%, remained the same in 44%, and even increased in 3%.[13]
Factors associated with phantom limb pain
This study could not find any predictors of PLP among the 
amputees; hence, the knotty question persists. The amputees 
who were ASA Grade II were seven times more likely to 
experience PLP when compared with those who were classified 
as ASA Grade I and IV, but this was not statistically significant. 
This anesthetic index has not been considered in previous 
studies on PLP.
Treatment of phantom limb pain
PLP is considered a neuropathic pain, and most current 
treatments are based on general recommendations for 
neuropathic pain syndromes as mechanism‑based specific 
treatment protocols recommended by Woolf and Mannion[31] 
are yet to evolve in view of the clinical challenge in determining 
which mechanisms may be operating in individual patients.
In this study, the treatment modality offered to the few treated PLP 
sufferers by their physicians was pharmacotherapy, consisting 
of diclofenac, paracetamol, carbamazepine, pregabalin, and 
chlorzoxazone. In a retrospective survey of 537 amputees 
in Germany, Kern et al. found that the vast majority of their 
PLP patients (71.1%) did not try any treatment, but among 
those who sought treatment, 30% consulted 4–20 physicians 
in search of beneficial treatment.[32] The magnitude of neglect 
and despair suffered by this subpopulation of amputees in 
both the Nigerian and German studies are reflections of 
the underrecognition and undertreatment of PLP across 
national frontiers. Another retrospective, questionnaire-based 
cross-sectional study involving American adult lower-limb 
amputees had revealed that pharmacotherapy was the most 
commonly used modality for PLP, with acetaminophen and 
opioids being most frequently used (both by 22% each), followed 
by nonsteroidal anti‑inflammatory drugs (NSAIDs) (20%), 
even as acetaminophen and NSAIDs were rated to be of low 
helpfulness. Although nonpharmacological modalities were 
less frequently used: physical therapy (16%), massage (8%), 
transcutaneous electrical nerve stimulation (TENS) (7%), 
chiropractic care (4%), acupuncture (1%), and marijuana (1%), 
they were generally rated to be of moderate to high helpfulness.[33]
Similarly, in a survey of British amputees with PLP, the most 
frequently used pharmacotherapy was acetaminophen (53%) 
or an acetaminophen-opioid combination (37%), with more 
than 50% of the respondents each reporting satisfaction with 
the acetaminophen-opioid combination, NSAIDs, and alcohol, 
whereas the most common nonpharmacological therapy 
was TENS (36%), and 42% of the respondents who used 
TENS expressed satisfaction with this form of treatment.[13] 
New treatment approaches, such as mirror therapy which is 
simple and inexpensive, have been developed as a result of 
Ramachandran’s research using “virtual reality box”[34] and 
is promising.[35] A randomized controlled trial[36] found both 
mirror therapy and TENS to be effective in pain reduction 
on a short‑term basis, but no difference was found between 
the two modalities of treatment. In spite of the multiplicity 
of interventions applied for PLP treatment, a 2017 review 
involving 38 currently used therapies concluded that no 
decisions can be made for the first‑line management of PLP, 
as the level of evidence in favor of any therapy is too low.[37]
The paucity of literature on PLP in Nigeria is rather astonishing 
and negates the high rate of amputation in several published 
works in the country, and with the finding of high prevalence 
of PLP in this study, one may infer that a vast population of 
limb amputees in Nigeria and indeed Africa are suffering the 
PLP scourge, albeit silently.
It is noteworthy that most of the published works on PLP 
cited here, or otherwise, are retrospective and cross-sectional 
studies in which the pain was sampled at a single point in time 
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and different results may have been obtained if patient’s pain 
was tracked over time, like in a prospective, cohort study as 
this. The latter method could also increase recovery rates and 
reduce dropout rate of the amputees leading to higher validity 
of the results.
Limitations of the study
Beyond sensory intensity and perceptual quality of the PLP 
which were captured in the study, other important domains 
of neuropathic pain such as affect intensity (bothersome, 
anxiety, anger, depression, sleep disturbances, etc.) and 
temporal features (episodic, constant, fluctuating, etc.) 
could have been better captured with multidimensional pain 
assessment tools such as the McGill Pain Questionnaire 
and the Brief Pain Inventory, but these are rarely suitable 
in this clinical setting. Furthermore, actual PLP prevalence 
among the amputees in this study might have been 
underestimated since the cohort was followed up for only 
1 year postamputation, whereas PLP onset may indeed 
be delayed for decades in some susceptible amputees, as 
revealed in a case report.[38]
conclusIon
Despite scant mention in the regional literature, PLP is highly 
prevalent but untreated among limb amputees in Nigeria and 
indeed Africa. It is hoped that this modest effort will galvanize 
awareness and improved practice relating to PLP among 
health-care providers in Africa, considering the vast population 
of amputees in the region.
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